Neogenix Oncology, Inc.
Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibody
Published in Hospital Business Week, February 28th, 2010
NPC-1C is a novel, chimeric monoclonal antibody intended for the treatment of advanced pancreatic and colorectal cancer, and is the first of the Neogenix pipeline of antibodies that target specific cancers. Pre-clinical studies have demonstrated that NPC-1 specifically targets pancreatic and colorectal cancer sparing healthy tissue.
"We are pleased to partner with the investigators at Johns Hopkins on this study and we look forward...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Allegheny General Hospital
Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment - Allied Healthcare Products, Inc.
Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions - Allscripts-Misys Healthcare Solutions, Inc.
NuHealth Selects Allscripts for Electronic Health Record, Practice Management and Emergency Department Automation - Allscripts-Misys Healthcare Solutions, Inc.
Self Regional Healthcare Selects Allscripts Electronic Health Record and Practice Management for Employed and Affiliated Physicians - American Academy of Neurology
Can Chocolate Lower Your Risk of Stroke? - American Academy of Neurology
Headache May Linger Years Later in People Exposed to World Trade Center Dust, Fumes - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
